Bredt David's Form 4 filing
Rapport Therapeutics, Inc. (RAPP) · filed Aug 18, 2025
- Accession no.
- 0000950170-25-109838
- Filed
- Aug 18, 2025
- Trade date
- Aug 15, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $127.5K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bredt DavidCIK 0002022087 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Common Stock | SSaleDisposed | −8,300 | $14.98 | −$124,334 | 426,842 | Direct | |
| Aug 15, 2025 | Common Stock | SSaleDisposed | −200 | $15.79 | −$3,158 | 426,642 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.